Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandutinib in metastatic clear cell renal cell carcinoma
NCT00408902Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2006
- Primary completion
- Oct 2008
- Countries
- 1
01
Overview
A Phase 2 trial of tandutinib in clear cell renal cell carcinoma (ccRCC), sponsored by National Cancer Institute. Started Nov 2006; status: completed.
02
Drugs
tandutinib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT00408902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408902.